30 March 2022

GSK Stockmann advises Mediocredito Centrale regarding a guarantee agreement with the European Investment Fund

GSK Stockmann provided comprehensive legal advice to Mediocredito Centrale S.p.A. (MCC) in relation to a guarantee agreement with the European Investment Fund (EIF).

The guarantee is a structured finance product whereby MCC will establish an up to EUR 50,000,000 portfolio of loans to be granted to Italian small medium enterprises (SMEs) in the course of 2022, and the EIF will guarantee payments under the loan portfolio, thus increasing the financing capacity of MCC.

The uncapped guarantee benefits from the support of the Pan-European Guarantee Fund, established by certain Member States of the European Union to respond to the economic impact of the COVID-19 pandemic outbreak.

The guarantee agreement is governed by the Luxembourg law of 10 July 2020 on professional payment guarantees, a new Luxembourg law which facilitates the set-up of structured finance products in the form of guarantees.

MCC is an Italian bank specialized in medium-term loan to companies, in particular SMEs based in central and south of Italy.

Legal advisers of MCC:

GSK Stockmann (Luxembourg law): Valerio Scollo (Securitisation & Structured Finance, Lead); Julia Kaalikoski (Associate, Securitisation & Structured Finance).

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Valerio Scollo, LL.M.

Local Partner

+352 271802-32

valerio.scollo@gsk-lux.com

Julia Kaalikoski, LL.M.

Associate

+352 271802-361

julia.kaalikoski@gsk-lux.com

© GSK Stockmann 2022